Copyright © 2002 by the European Society of Cardiology.
Editorials
Greek technology or mythology?
Oosterbeek, The Netherlands
References
- Stafanadis C. Stain treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J. 2002;23:16641669
[Abstract/Free Full Text] - Ridker PM, Rifai N, Pfeffer MA. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998;98:839844
[Abstract/Free Full Text] - Eur Heart J. 1999;20:725741
[Abstract/Free Full Text] - The ENCORE Group, Functional impairment of visually non- or minimally atherosclerotic coronary arteries: Insight from the ENCORE trial, Circulation
- Mancini JGB, Henry GC, Macaya C. Angiotensin converting enzyme inhibition with Quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND Trial. Circulation. 1996;94:258265
[Abstract/Free Full Text] - Serruys, PW, The LIPS Trial, JAMA
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||